Pancreaticoduodenal allotransplantation with the use of FK 506, cyclosporine, and triple-regimen immunosuppression.
Imai
K
K
Department of Surgery, Kitasato University, School of Medicine, Kanagawa, Japan.
Sato
K
K
Takishima
T
T
Nakayama
Y
Y
Osakabe
T
T
Yokota
K
K
Yamagishi
K
K
Uchida
H
H
Hiki
Y
Y
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D003524:Cyclosporins / Q000627:therapeutic use*; D004285:Dogs; D004359:Drug Therapy, Combination; D004386:Duodenum / Q000637:transplantation*; D005260:Female; D006084:Graft Rejection; D006085:Graft Survival; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D016035:Pancreas Transplantation / Q000276:immunology* / Q000473:pathology; D012263:Ribonucleosides / Q000627:therapeutic use*; D016559:Tacrolimus; D013997:Time Factors; D014184:Transplantation, Homologous / Q000276:immunology
D000900:Anti-Bacterial Agents; D003524:Cyclosporins; D007166:Immunosuppressive Agents; D012263:Ribonucleosides; C010052:mizoribine; D016559:Tacrolimus